Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.
Lívia Dos Remédios Pamplona de OliveiraTarsila Campanha da Rocha RibeiroCarlos Alberto Mourão-JúniorMaria Antônia de Lima BarraMariana Hippert Gonçalves SilvaLuis Pordeus ShafeeSarah Mendes ZacariasLenilton da Costa CamposHelena Maria Giordano ValérioJúlio Maria Fonseca ChebliPublished in: Revista da Associacao Medica Brasileira (1992) (2024)
A high prevalence of metabolic dysfunction-associated steatotic liver disease was observed in patients with inflammatory bowel disease, with the main risk factors being associated with metabolic syndrome predicting it, but not with inflammatory bowel disease features and/or its treatment.